Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Global burden of bacterial antimicrobial...

Los médicos tardan en usar antibióticos nuevos y efectivos contra las superbacterias.

Los médicos tardan en usar antibióticos nuevos y...

Principal causes for hospital readmission identified

A group of physicians in Canada examined a...

‘Anti-antibiotic’ allows for use of antibiotics without driving resistance

ScienceDaily recently reported on the promising...

WHO launches first ever global report on infection prevention and control

WHO launches first ever global report on...

Antibiotic resistance: World on cusp of ‘post antibiotic era’

The world is on the cusp of a "post-antibiotic...

Audio Interview: Building a Successful Public Health Response to Covid-19

The continuing spread of SARS-CoV-2 remains a...